Curefit will be tested
Mukesh Bansal’s Curefit has all the funding it needs, but little semblance of a strategy.
We rarely make our stories free to read. This one is, so make the most of it.
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
No payment details required
$99 for one year
More in Internet
You may also like
Curefoods takes an old-school shot at a public listing
The Bengaluru-based startup has set its sights on an IPO all too quickly. A good mix of tech and services at a reasonable valuation might be its drawcard.
Pakistan’s failed startup promise, competition force Careem’s exit
The most popular startup of the Middle Eastern region just exited its decade-old operation in the country, citing competition and macro challenges. Both these reasons need to be unpacked and understood separately.
In India, everything is logistics
Large, valuable businesses are being built in the country, many of whom are delivering food, grocery, goods, services and even people. At their core, these two-sided marketplaces are solving for efficient logistics.